Joseph Patrick Erinjeri MD PhD
Member, Memorial Sloan Kettering Cancer Center Professor of Radiology, Weill Cornell Medical College
530 East 74th StreetNew York, NY 10021
Overview of Dr. Erinjeri
Dr. Joseph Erinjeri is an Interventional Radiologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Washington University in St. Louis School of Medicine and has been in practice 24 years. Dr. Erinjeri accepts several types of health insurance, listed below. He is one of 35 doctors at Memorial Sloan Kettering Cancer Center and one of 3 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Interventional Radiology. He has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Vascular and Interventional Radiology, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2007 - 2008
Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 2003 - 2007
Virginia Mason Franciscan HealthInternship, Internal Medicine, 2002 - 2003- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2007 - 2028
NJ State Medical License 2017 - 2027
CT State Medical License 2025 - 2026
PA State Medical License 2025 - 2026
American Board of Radiology Diagnostic Radiology- American Board of Radiology Vascular & Interventional Radiology
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 2 citationsOutcomes following microwave ablation of 669 primary and metastatic lung malignancies.Ruben Geevarghese, Erica S Alexander, Ahmed Elsakka, Olivier Chevallier, Luke Kelly
European Radiology. 2026-03-01 - Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, Jasme Lee, Mathew Adamow
Cancer Research Communications. 2026-02-01 - Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig Model.Hooman Yarmohammadi, Sam Y Son, Aaron W P Maxwell, Ahmed S Elsakka, Vlasios S Sotirchos
Journal of Vascular and Interventional Radiology. 2026-02-01
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
- Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
- Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
Schedule at A GlanceJune 8th, 2015
Professional Memberships
- Member
Insurance Accepted
- CIGNA Open Access
CIGNA PPO
GHI PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPOOxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
